创伤性休克的药物处理进展  

Progress of traumatic shock drug treatment

作　　者：张赛龙 周东[2] 田泾[3] 陈盛新[4] 

机构地区：[1]第二军医大学,药学本科07级上海200433 [2]第二军医大学研究生院,上海200433 [3]第二军医大学长海医院药学部,上海200433 [4]第二军医大学药学院,上海200433

出　　处：《药学实践杂志》2009年第6期407-410,429,共5页Journal of Pharmaceutical Practice

基　　金：上海市重点学科建设项目资助(B907)

摘　　要：创伤性休克是危害人类生命的严重病症,抗休克治疗是创伤救治中挽救生命的首要措施。无论是战伤救治,还是平时院前急救或院后治疗,合理的抗休克处理,对于保障伤员的生命安全具有重要意义。药物治疗是创伤性休克处理的必要手段,其中抗休克药物的选择和给药的策略尤为关键。本文综述近年来创伤性休克药物的临床应用进展及给药策略。Objective：Traumatic shock is a serious disease which endangers human beings life. The treatment of shock is the most important measure to save life. It is highly important to apply properly method of treating shock whenever it is for healing battle wound or pre-hospital medical care or post-hospital therapy. Pharmacotherapy is a necessary method of dealing with traumatic shock, especially for the drug selection and the strategy of drug administration. This review examines the progress of traumatic shock drug during these years and the strategy of drug administration.

关 键 词：创伤性休克 抗休克药物 给药策略 

分 类 号：R972.5[医药卫生—药品]